Baird Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123M Buy
339,825
+5,496
+2% +$1.88M 0.17% 93
2026
Q1
$118M Buy
334,329
+46,347
+16% +$16.5M 0.18% 89
2025
Q4
$94.3M Buy
287,982
+6,163
+2% +$1.95M 0.15% 103
2025
Q3
$79.5M Sell
281,819
-2,709
-1% -$786K 0.13% 127
2025
Q2
$79.4M Sell
284,528
-24,670
-8% -$6.99M 0.14% 122
2025
Q1
$96.3M Sell
309,198
-26,571
-8% -$7.85M 0.19% 100
2024
Q4
$87.5M Sell
335,769
-10,812
-3% -$3.21M 0.17% 107
2024
Q3
$112M Buy
346,581
+12,324
+4% +$4.03M 0.22% 94
2024
Q2
$104M Sell
334,257
-8,830
-3% -$2.59M 0.22% 94
2024
Q1
$97.5M Sell
343,087
-12,262
-3% -$3.59M 0.2% 109
2023
Q4
$102M Buy
355,349
+44,105
+14% +$12M 0.23% 98
2023
Q3
$83.6M Buy
311,244
+1,242
+0.4% +$310K 0.23% 99
2023
Q2
$68.8M Sell
310,002
-67,447
-18% -$15.7M 0.18% 133
2023
Q1
$91.2M Sell
377,449
-13,567
-3% -$3.33M 0.23% 101
2022
Q4
$103M Sell
391,016
-4,662
-1% -$1.25M 0.27% 76
2022
Q3
$89.2M Sell
395,678
-36,111
-8% -$8.75M 0.26% 87
2022
Q2
$105M Buy
431,789
+52,024
+14% +$12.7M 0.29% 71
2022
Q1
$91.8M Sell
379,765
-51,173
-12% -$11.8M 0.23% 94
2021
Q4
$96.9M Buy
430,938
+14,027
+3% +$2.96M 0.23% 100
2021
Q3
$88.7M Buy
416,911
+2,990
+0.7% +$688K 0.23% 105
2021
Q2
$101M Buy
413,921
+51,809
+14% +$12.7M 0.26% 84
2021
Q1
$90.1M Sell
362,112
-21,642
-6% -$5.16M 0.25% 94
2020
Q4
$88.2M Buy
383,754
+10,082
+3% +$2.32M 0.26% 92
2020
Q3
$95M Buy
373,672
+9,918
+3% +$2.46M 0.33% 65
2020
Q2
$85.8M Sell
363,754
-20,832
-5% -$4.75M 0.32% 62
2020
Q1
$77.7M Sell
384,586
-29,647
-7% -$6.48M 0.35% 57
2019
Q4
$99.9M Buy
414,233
+9,998
+2% +$2.2M 0.36% 55
2019
Q3
$78.2M Buy
404,235
+10,924
+3% +$2.1M 0.31% 72
2019
Q2
$72.5M Buy
393,311
+72,999
+23% +$13.1M 0.28% 80
2019
Q1
$60.8M Sell
320,312
-30,843
-9% -$5.89M 0.36% 68
2018
Q4
$68.4M Buy
351,155
+33,736
+11% +$6.58M 0.46% 44
2018
Q3
$65.7M Sell
317,419
-27,929
-8% -$5.5M 0.41% 50
2018
Q2
$63.7M Buy
345,348
+14,885
+5% +$2.63M 0.43% 46
2018
Q1
$56.3M Buy
330,463
+6,963
+2% +$1.28M 0.4% 54
2017
Q4
$56.3M Sell
323,500
-7,067
-2% -$1.25M 0.4% 57
2017
Q3
$61.6M Sell
330,567
-8,970
-3% -$1.59M 0.46% 42
2017
Q2
$58.5M Buy
339,537
+15,628
+5% +$2.54M 0.46% 39
2017
Q1
$53.1M Buy
323,909
+175,629
+118% +$29.2M 0.43% 44
2016
Q4
$21.7M Buy
148,280
+13,840
+10% +$2.08M 0.19% 153
2016
Q3
$22.4M Buy
134,440
+2,434
+2% +$412K 0.2% 143
2016
Q2
$20.7M Sell
132,006
-15,912
-11% -$2.47M 0.19% 154
2016
Q1
$22.2M Buy
147,918
+23,927
+19% +$3.55M 0.21% 140
2015
Q4
$20.1M Sell
123,991
-951
-0.8% -$149K 0.2% 142
2015
Q3
$17.3M Buy
124,942
+3,368
+3% +$531K 0.18% 149
2015
Q2
$18.7M Buy
+121,574
New +$19.5M 0.18% 153

Other funds holding AMGN

Baird Financial Group's AMGN Position: Q2 2026 in Review

Baird Financial Group increased its Amgen (AMGN) stake by 1.6% in Q2 2026, buying an estimated $1.88M and bringing the position to 339,825 shares worth $123M. The position accounts for 0.17% of the portfolio, ranked #93.

Baird Financial Group first reported a position in AMGN in Q2 2015 and has held it in 45 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Baird Financial Group held 339,825 shares of Amgen worth $123M as of Q2 2026.
  • Baird Financial Group bought 5,496 Amgen shares in Q2 2026, an estimated $1.88M.
  • Amgen made up 0.17% of Baird Financial Group's portfolio in Q2 2026, its #93 holding.
  • Baird Financial Group first reported a position in Amgen in Q2 2015 and has held it in 45 quarters since.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.